Cannabis for Pediatric and Adult Epilepsy
Epilepsy is a chronic disease of the central nervous system characterized by recurrent unprovoked seizures. Up to 30% of patients continue to have seizures despite treatment with appropriate anticonvulsant medications. The presence of abnormal oscillatory events within neural networks is a major fea...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Ebooks |
| Published: |
IntechOpen,
2019-04-08.
|
| Subjects: | |
| Online Access: | Get Online |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| LEADER | 02290 am a22002173u 4500 | ||
|---|---|---|---|
| 001 | intechopen_books_7040 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Huntsman, Richard James |e author |
| 700 | 1 | 0 | |a Tang-Wai, Richard |e author |
| 700 | 1 | 0 | |a Tellez-Zenteno, Jose |e author |
| 245 | 0 | 0 | |a Cannabis for Pediatric and Adult Epilepsy |
| 260 | |b IntechOpen, |c 2019-04-08. | ||
| 500 | |a https://mts.intechopen.com/articles/show/title/cannabis-for-pediatric-and-adult-epilepsy | ||
| 520 | |a Epilepsy is a chronic disease of the central nervous system characterized by recurrent unprovoked seizures. Up to 30% of patients continue to have seizures despite treatment with appropriate anticonvulsant medications. The presence of abnormal oscillatory events within neural networks is a major feature of epileptogenesis. The endocannabinoid system can modulate these oscillatory events and alter neuronal activity making the phytocannabinoids found in Cannabis a potential therapeutic option for patients with treatment resistant epilepsy. Many in vitro and in vivo studies have demonstrated the anticonvulsant effects of several phytocannabinoids including Δ9-tetrahydrocannabinol (Δ9-THC) and Cannabidiol (CBD). Several small observational studies demonstrated a favorable response to cannabis herbal extracts (CHE) containing high concentrations of CBD in children with treatment resistant epilepsy. Two large double blinded clinical trials assessing the efficacy of pharmaceutical grade CBD have also been performed in children with treatment resistant seizures in Dravet syndrome and Lennox-Gastaut syndrome. Both studies demonstrated an improvement in seizure reduction in children taking CBD as compared to the placebo groups. To date there is very limited data regarding the use of cannabis based products to treat adult patients with treatment resistant epilepsy with only one randomized double blinded placebo controlled clinical trial underway. | ||
| 540 | |a https://creativecommons.org/licenses/by/3.0/ | ||
| 546 | |a en | ||
| 690 | |a Recent Advances in Cannabinoid Research | ||
| 655 | 7 | |a Chapter, Part Of Book |2 local | |
| 786 | 0 | |n https://www.intechopen.com/books/7040 | |
| 787 | 0 | |n ISBN:978-1-83880-151-9 | |
| 856 | \ | \ | |u https://mts.intechopen.com/articles/show/title/cannabis-for-pediatric-and-adult-epilepsy |z Get Online |